View in EDS PDF Full Text

Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study.

Saved in:
Bibliographic Details
Title: Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study.
Authors: Terpos, Evangelos1 (AUTHOR) eterpos@med.uoa.gr, Ntanasis-Stathopoulos, Ioannis1 (AUTHOR) mdeleutherakis@gmail.com, Katodritou, Eirini2 (AUTHOR) eirinikatodritou@gmail.com, Kyrtsonis, Marie-Christine3 (AUTHOR) kyrtsoni@med.uoa.gr, Douka, Vassiliki4 (AUTHOR) vassiliki.douka@gmail.com, Spanoudakis, Emmanouil5 (AUTHOR) emmanouilspanoudakis@yahoo.com, Papatheodorou, Athanasios6 (AUTHOR) atpapath@med.uoa.gr, Eleutherakis-Papaiakovou, Evangelos1 (AUTHOR) nick.kanellias@gmail.com, Kanellias, Nikolaos1 (AUTHOR) mariagabria@gmail.com, Gavriatopoulou, Maria1 (AUTHOR) ekastritis@gmail.com, Makras, Polyzois6 (AUTHOR) makras@internet.gr, Kastritis, Efstathios1 (AUTHOR) mdimop@med.uoa.gr, Dimopoulos, Meletios A1 (AUTHOR), Atanackovic, Djordje (AUTHOR)
Source: Cancers. Mar2021, Vol. 13 Issue 6, p1257. 1p.
Database: Academic Search Ultimate
Description
ISSN:20726694
DOI:10.3390/cancers13061257